Management of Arrhythmia: Atrial Fibrilation
DOI:
https://doi.org/10.53089/medula.v11i3.309Keywords:
atrial fibrillation, heart disfunction, aritmia managementAbstract
Abstract
Arrhythmias are a problem with the rate or rhythm of the heartbeat. The four main types of arrhythmias are premature or premature beats, ventricular arrhythmias, bradiarimia, and supraventricular arrhythmias. Supraventricular arrhythmias are tachycardia (rapid heartbeat) starting at the atrial or atrioventricular (AV). Types of supraventricular outbreaks include atrial fibrillation (AF), atrial flutter, paroxysmal supraventricular tachycardia (PSVT), and Wolff-Parkinson-White syndrome (WPW). Atrial fibrillation is the most common type of arrhythmia. In general, the management of AF patients has 5 objectives: thromboembolic events, coping with AF related symptoms, optimal management of accompanying cardiovascular disease, controlling heart rate, and improving rhythm disturbance. Antithrombotic therapy used for stroke prevention in FA patients includes anticoagulants (vitamin K or AVK antagonists and new anticoagulants or IMR), and antiplatelets. AKB which is not AVK in Indonesia market, that is dabigatran, rivaroxaban, and apixaban. Dabigatran works by dealing directly with trombinlah rivaroxaban and apixabanacas works by presenting the Xa factor.
References
National Heart, Lung, and Blood [internet]. Spanyol: National Heart, Lung, and Blood; 2017 [disitasi 9 Desember 2017]. Tersedia dari: https://www.nhlbi.nih.gov/health-topics/arrhythmia.
Durham D, Worhley LIG. Cardiac arrhythmias: diagnosis and management. The tachycardias. Critical Care and Resusitaion. 2002; 4:35-53.
St. George-Hyslop C, Morton C, Daley E [internet]. Neonatal and pediatric guidelines for arrhythmia management [disitasi 9 Desember 2017]. Tersedia dari: http://www.pcics.org/wp-content/uploads/2014/12/Neo_Pedia_Guidelines_Arrhythmia.pdf
Perhimpunan Doker Spesialis Kardiovaskular Indonesia. Pedoman tata laksana fibrilasi atrium. Centra Communication; 2014.
Camm AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2012;14:1385-413.
Yansen I, Yuniadi Y. Tata laksana fibrilasi atrium: kontrol irama atau laju jantung. Cermin Dunia Kedokteran. 2013;40(3):171-5.
European Heart Rhythm A, European Association for Cardio-Thoracic S, Camm AJ, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2010;12:1360-420.
Defaye P, Dournaux F, Mouton E. Prevalence of supraventricular arrhythmias from the automated analysis of data stored in the DDD pacemakers of 617 patients: the AIDA study. The AIDA Multicenter Study Group. Automatic Interpretation for Diagnosis Assistance. Pacing and clinical electrophysiology. 1998;21:250-5.
Medscape [internet]. Atrial Fibrillation Clinical Presentation [disitasi 9 Desember 2017]. Tersedia dari: http://emedicine.medscape.com/article/151066-clinical.
Wann LS, Curtis AB, January CT, et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology. 2011;57:223-42.
European Heart Rhythm A, European Association for Cardio-Thoracic S, Camm AJ, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2010;12:1360-420.
Group SRiAFW. Independent predictors of stroke in patients with atrial fibrillation: a systematic review. Neurolog 2007;69:546-54.
Friberg L, Rosenqvist M, Lip GY. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. European heart journal. 2012;33:1500-10.
Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. The New England journal of medicine. 2009;361:1139-51.
Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883-91.
Connolly SJ, Eikelboom J, Joyner C, Diener HC, Hart R, Golitsyn S, et al. Apixaban in patients with atrial fibrillation. N Engl J Med. 2011;364(9):806-817.
Allen, H., Gutgesell, H., Clark, E., Driscoll, D. (2001). Moss and Adams’ Heart disease in infants, children and adolescents including the fetus and the young. 6th Edition, Volume 1. Lippincott Williams and Wilkins. Philadelphia.
Kleinman ME, Chameides L, Schexnayder S M, Samson RA, Hazinski MF, Atkins DL, Zaritsky AL. Part 14: Pediatric Advanced Life Support: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2010; 122(18_suppl_3): S876-S908. doi: 10.1161/CIRCULATIONAHA.110.971101
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Medical Profession Journal of Lampung
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
